Structure-based Mapping of DAF Active Site Residues That Accelerate the Decay of C3 Convertases (Q58210854)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395591%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Structure-based mapping of DAF active site residues that accelerate the decay of C3 convertases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395591%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395591%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

7

Paul N Barlow

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395591%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Lisa Kuttner-Kondo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395591%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Nasima Muqim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395591%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Lynne Mitchell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395591%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Dennis E Hourcade

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395591%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Vernon E Anderson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395591%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

M Edward Medof

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395591%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

language of work or name

English

0 references

publication date

29 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395591%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Chemistry

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395591%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

282

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395591%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395591%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

18552-18562

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395591%20AND%20SRC:MED&resulttype=core&format=json

Control of the amplification convertase of complement by the plasma protein beta1H

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Complement receptor is an inhibitor of the complement cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Solution structure of a functionally active fragment of decay-accelerating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

The structure of echovirus type 12 bound to a two-domain fragment of its cellular attachment protein decay-accelerating factor (CD 55)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Complement regulation at the molecular level: The structure of decay-accelerating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Characterization of the active sites in decay-accelerating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Identification of functional domains in kaposica, the complement control protein homolog of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Dissecting Sites Important for Complement Regulatory Activity in Membrane Cofactor Protein (MCP; CD46)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Immunophysical properties and prediction of activities for vaccinia virus complement control protein and smallpox inhibitor of complement enzymes using molecular dynamics and electrostatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Mutations in alpha-chain of C4BP that selectively affect its factor I cofactor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Positively charged amino acids at the interface between alpha-chain CCP1 and CCP2 of C4BP are required for regulation of the classical C3-convertase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Structure of the C3b binding site of CR1 (CD35), the immune adherence receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Identification of complement regulatory domains in vaccinia virus complement control protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Structure-function relationships of complement receptor type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Synergy between two active sites of human complement receptor type 1 (CD35) in complement regulation: implications for the structure of the classical pathway C3 convertase and generation of more potent inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

The Kaposi's sarcoma-associated herpesvirus complement control protein mimics human molecular mechanisms for inhibition of the complement system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) open reading frame 4 protein (kaposica) is a functional homolog of complement control proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611650200

21 January 2018

Identifiers

DOI

10.1074/JBC.M611650200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17395591%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference